FIELD: chemistry.
SUBSTANCE: invention relates to polypeptides that act as modulators of complement activity, pharmaceutical compositions containing said polypeptides, and methods of using such modulators as therapeutic agents.
EFFECT: treatment of complement-related diseases, for example, such as inflammatory disease, wound, injury.
18 cl, 7 dwg, 18 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPLEMENT ACTIVITY MODULATION | 2015 |
|
RU2778514C2 |
| INHIBITORS OF XA FACTOR | 1995 |
|
RU2152954C1 |
| PEPTIDOMIMETIC MACROCYCLES | 2011 |
|
RU2582678C2 |
| COMPOUND WHICH IS CALCIUM-SENSITIVE RECEPTOR AGONIST, AND USE THEREOF | 2020 |
|
RU2827834C1 |
| p53 PEPTIDOMIMETIC MACROCYCLES | 2013 |
|
RU2642299C2 |
| METHOD (VERSIONS) AND PREPARATION FOR MODIFICATION OF EATING BEHAVIOUR | 2002 |
|
RU2519748C2 |
| POTENT COMPSTATIN ANALOGS | 2012 |
|
RU2656102C2 |
| NOVEL POLYPEPTIDES | 2014 |
|
RU2674604C2 |
| COMPLEMENT ACTIVITY MODULATORS | 2017 |
|
RU2778811C2 |
| CELL-REACTIVE COMPSTATIN ANALOGS, LONG-ACTING COMPSTATIN ANALOGS, OR TARGETED COMPSTATIN ANALOGS AND USES THEREOF | 2012 |
|
RU2653439C9 |
Authors
Dates
2018-10-29—Published
2015-06-12—Filed